Sigma1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1149-1152

  Skuza, Grazyna ^a   Rogóz, Zofia ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

BD 1047; DTG; Forced swimming test; Memantine; Progesterone; Rats; Sigma ligands; Synergistic effect

Indexed keywords

1,3 DI O TOLYLGUANIDINE; ANTIDEPRESSANT AGENT; MEMANTINE; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (DIMETHYLAMINO)ETHYLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE AGONIST; OPIATE ANTAGONIST; PROGESTERONE; RECEPTOR SUBTYPE; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; 1,3 DITOLYLGUANIDINE; 1,3-DITOLYLGUANIDINE; GUANIDINE DERIVATIVE; SIGMA 2 OPIATE RECEPTOR; SIGMA-1 RECEPTOR; SIGMA-2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG RESPONSE; FORCED SWIMMING TEST; MALE; NONHUMAN; RAT; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; MOTOR ACTIVITY; PHYSIOLOGY; SWIMMING; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GUANIDINES; MALE; MEMANTINE; MOTOR ACTIVITY; PROGESTERONE; RATS; RATS, WISTAR; RECEPTORS, SIGMA; SWIMMING;

EID: 1642543862     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Akunne H.C., Zoski K.T., Whetzel S.Z., Cordon J.J., Brandon R.M., Roman F., Pugsley T.A.: Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant. Neuropharmacology, 2001, 41, 138-149.
2. Kornhuber J., Schoppmeyer K., Riederer P.: Affinity of 1-aminoadamantanes for the σ binding site in postmortem human frontal cortex. Neurosci. Lett., 1993, 163, 129-131.
3. Leonard B.E.: The potential contribution of sigma receptors to antidepressant actions. In: Antidepressants: New Pharmacological Strategies. Ed. Skolnick P., Humana Press, Totowa, 1997, 159-172.
4. Martin W.R., Eades C.G., Thompson J.A., Huppler E., Gilbert P.E.: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 1976, 197, 517-532.
5. Matsumoto R.R., Bowen W.D., Tom M.A., Vo V.N., Truong D.D., De Costa B.R.: Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism. Eur J. Pharmacol., 1995, 280, 301-310.
6. 3H]SKF 10,047 binding to sigmal receptors in mouse forebrain. J. Neurosci. Res., 1996, 46, 734-743.
7. Monnet F.P., Debonnel G., Junien J.-L., de Montigny C.: N-Methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors. Eur. J. Pharmacol., 1990, 179, 441-445.
8. Porsolt R.D., Anton G., Blavet N., Jalfre M.: Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 1978, 47, 379-391.
9. Quirion R., Bowen W.D., Itzhak Y., Junien J.M., Mussacchio J.M., Rothman T.P., Su T.P., Tam S.W., Taylor D.P.: A proposal on the classification of sigma binding sites. Trends Pharmacol. Sci., 1992, 13, 85-86.
10. Rogóz Z., Skuza G., Maj J., Danysz W.: Synergistic effects of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology, 2002, 42, 1024-1030.
11. Sánchez C., Meier E.: Behavioural profile of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology, 1997, 129, 197-205.
12. Seth P., Fei Y.J., Li H.W., Huang W., Leibach F.H., Ganapathy V.: Cloning and functional characterization of a sigma receptor from rat brain. J. Neurochem., 1998, 70, 22-31.
13. Skuza G., Rogóz Z.: Effect of combined treatment with selective σ ligands and amantadine in the forced swimming test in rats. Pol. J. Pharmacol., 2002, 54, 699-702.
14. 1A receptor agonist OPC-14523. Neuropharmacology, 2001, 41, 976-988.